Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen M Taylor

Showing results (11-20 of 66) with videos related to

Pageof 7
Sort By:
Advances in Experimental Medicine and Biology|August 9, 2006
Transdermal pharmacology of small molecule cyclic C5a antagonistsLavinia M Proctor, Trent M Woodruff, Prakirti Sharma, et al.
Clinical and Experimental Pharmacology & Physiology|October 9, 2002
Pirfenidone attenuates ischaemia-reperfusion injury in the rat small intestineThiruma V Arumugam, Ian A Shiels, Solomon B Margolin, et al.
Shock (Augusta, Ga.)|April 17, 2004
The role of the complement system in ischemia-reperfusion injuryThiruma V Arumugam, Ian A Shiels, Trent M Woodruff, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 15, 2012
C5L2: a controversial receptor of complement anaphylatoxin, C5aRui Li, Liam G Coulthard, M C L Wu, et al.
Stem Cells (Dayton, Ohio)|August 19, 2014
Brief report: complement C5a promotes human embryonic stem cell pluripotency in the absence of FGF2Owen A Hawksworth, Liam G Coulthard, Stephen M Taylor, et al.
Neuromolecular Medicine|September 19, 2009
The role of the complement system and the activation fragment C5a in the central nervous systemTrent M Woodruff, Rahasson R Ager, Andrea J Tenner, et al.
Journal of Neuroinflammation|June 23, 2012
Complement activation in the injured central nervous system: another dual-edged sword?Faith H Brennan, Aileen J Anderson, Stephen M Taylor, et al.
Shock (Augusta, Ga.)|November 15, 2008
Toll-like receptors in ischemia-reperfusion injuryThiruma V Arumugam, Eitan Okun, Sung-Chun Tang, et al.
Arthritis Research & Therapy|March 16, 2011
Comparative efficacy of a secretory phospholipase A2 inhibitor with conventional anti-inflammatory agents in a rat model of antigen-induced arthritisLiam G Coulthard, Jaclyn Costello, Brent Robinson, et al.
Journal of Neurotrauma|February 9, 2017
The Alternative Receptor for Complement Component 5a, C5aR2, Conveys Neuroprotection in Traumatic Spinal Cord InjuryPatrick J C Biggins, Faith H Brennan, Stephen M Taylor, et al.
Pageof 7

Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
Advances in Experimental Medicine and Biology|August 9, 2006
Transdermal pharmacology of small molecule cyclic C5a antagonistsLavinia M Proctor, Trent M Woodruff, Prakirti Sharma, et al.
Clinical and Experimental Pharmacology & Physiology|October 9, 2002
Pirfenidone attenuates ischaemia-reperfusion injury in the rat small intestineThiruma V Arumugam, Ian A Shiels, Solomon B Margolin, et al.
Shock (Augusta, Ga.)|April 17, 2004
The role of the complement system in ischemia-reperfusion injuryThiruma V Arumugam, Ian A Shiels, Trent M Woodruff, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 15, 2012
C5L2: a controversial receptor of complement anaphylatoxin, C5aRui Li, Liam G Coulthard, M C L Wu, et al.
Stem Cells (Dayton, Ohio)|August 19, 2014
Brief report: complement C5a promotes human embryonic stem cell pluripotency in the absence of FGF2Owen A Hawksworth, Liam G Coulthard, Stephen M Taylor, et al.
Neuromolecular Medicine|September 19, 2009
The role of the complement system and the activation fragment C5a in the central nervous systemTrent M Woodruff, Rahasson R Ager, Andrea J Tenner, et al.
Journal of Neuroinflammation|June 23, 2012
Complement activation in the injured central nervous system: another dual-edged sword?Faith H Brennan, Aileen J Anderson, Stephen M Taylor, et al.
Shock (Augusta, Ga.)|November 15, 2008
Toll-like receptors in ischemia-reperfusion injuryThiruma V Arumugam, Eitan Okun, Sung-Chun Tang, et al.
Arthritis Research & Therapy|March 16, 2011
Comparative efficacy of a secretory phospholipase A2 inhibitor with conventional anti-inflammatory agents in a rat model of antigen-induced arthritisLiam G Coulthard, Jaclyn Costello, Brent Robinson, et al.
Journal of Neurotrauma|February 9, 2017
The Alternative Receptor for Complement Component 5a, C5aR2, Conveys Neuroprotection in Traumatic Spinal Cord InjuryPatrick J C Biggins, Faith H Brennan, Stephen M Taylor, et al.
Pageof 7